$AIP

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991q2fy268-k.htm EX-99.1 Document Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor techn

Original reporting
Published Aug 6, 2026, 8:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AIP
Bullish
medium confidence
Mentioned
$AIP
Relevance
9/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AIPBullishHigh
01

Why it matters

Traders can update models immediately using the disclosed Q3 and FY ranges for ACV plus royalties, revenue, non-GAAP operating loss, and free cash flow, and reassess demand durability via RPO and design-start growth.

02

Market read

The filing is a direct earnings-and-guidance update with quantified ranges and multiple AI compute-linked demand indicators, making it actionable for positioning around the conference call.

03

What to watch

Free cash flow guidance is provided for Q3 ($5.0-$9.0M) but the company stops quarterly free cash flow guidance going forward, which can increase uncertainty for near-term modeling.

Relevance 9/10Novelty 9/10Timing: after-hours guidance and Q2 results filed Aug 6, 2026, ahead of the 4:30PM ET conference call

Background

This is an SEC Form 8-K (Item 2.02) with Arteris Q2 2026 financial results and updated third-quarter and full-year 2026 guidance.

Company-level read

Ticker impact

$AIPBullishMedium confidence
Context

Arteris reported Q2 results and updated 2026 guidance, including Q3 ACV plus royalties $99.0-$103.0M and FY revenue $95.0-$98.0M.

Expected impact

Near-term upside bias if investors view the guidance as credible and the RPO/design-start momentum as durable; downside risk if margins or cash flow underwhelm versus expectations.

Evidence & confidence

The filing provides fresh, quantified forward guidance and multiple record/YoY growth metrics (revenue +46%, ACV+royalties +44%, RPO +36%) plus a CFO transition starting Sept. 8, 2026.

Market effects

Semiconductor IP and NoC/SoC software demand signals remain tied to AI compute and data-center chiplet development, potentially supporting sentiment for adjacent design-enablement names.

Primarily US-listed small-cap tech sentiment; limited direct regional spillover beyond Nasdaq semiconductor complex.

Mentions China EV and Arm partnership expansion, which can influence global AI compute supply-chain narratives.

Counterpoint

Despite record ACV and RPO, the company still reports GAAP operating and net losses, so the stock may re-rate only if investors believe profitability and cash flow inflect sustainably.

Key entities

  • Arteris, Inc.

    Semiconductor technology provider reporting Q2 results and updated 2026 guidance, including record ACV plus royalties and RPO.

  • Saurabh Sinha

    Incoming CFO starting September 8, 2026, joining from Aeva Technologies.

  • Arm

    Expanded partnership by licensing Arteris hardware security assurance technology for selected Arm CPUs.

Related articles

$CGTXMed

COGNITION THERAPEUTICS INC (CGTX): Results of Operations and Financial Condition

COGNITION THERAPEUTICS INC (CGTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622462d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update Purchase, NY – August 6, 2026 – Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing pr

$BARKMed

Bark, Inc. (BARK): Results of Operations and Financial Condition

Bark, Inc. (BARK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q1fy27earningsrelease.htm EX-99.1 Document BARK Reports Fiscal First Quarter 2027 Results NEW YORK, August 6, 2026 — BARK, Inc. (NYSE: BARK) (“BARK” or the “Company”), a leading global omnichannel dog brand with a mission to make all dogs happy, today announced its fina

$VHIMed

VALHI INC /DE/ (VHI): Results of Operations and Financial Condition

VALHI INC /DE/ (VHI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 vhl-20260806xex99d1.htm EX-99.1 ‌ ​ ​ ​ ‌ ​ ​ ​ ​ VALHI REPORTS SECOND QUARTER 2026 RESULTS ​ DALLAS, TEXAS . . August 6, 2026. Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $22.3 million, or $.78 per share, in the second quarter of 2

$PHUNMed

Phunware, Inc. (PHUN): Results of Operations and Financial Condition

Phunware, Inc. (PHUN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 phun-ex99_1.htm EX-99.1 EX-99.1 Phunware Reports Second Quarter 2026 Financial Results Revenue Increased 76% Year-Over-Year, Gross Margin Expanded to 69% Maintained $92 Million Cash Position with No Debt to Support Continued Product Innovation and Growth Appointed Chief